Imatron CT Scanner Picked For NIH Cardiovascular Disease Screening Study
This article was originally published in The Gray Sheet
Imatron says the selection of its Ultrafast electron beam computed tomography (EBCT) scanner by the National Heart, Lung and Blood Institute for an upcoming screening study cements the scanner's position as the "gold standard" for assessment of baseline cardiac risk.
You may also be interested in...
Imatron Inc. is critical of research methods the American College of Cardiology and the American Heart Association used to compile an expert consensus document concluding that electron beam computed tomography demonstrates roughly 70% accuracy in predicting cardiac conditions in symptomatic patients.
Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies
Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.